Has Costas Bizekis, MD received payments from drug or device companies?

Yes. Drug and device makers reported $320,643 in general payments to Costas Bizekis, MD across 275 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Costas Bizekis, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Costas Bizekis, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Costas Bizekis, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · New York, NYNPI 1518967892

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $209,120 of the $320,643 with a category attached, or 65.2%. 22 manufacturers reported payments, led by US Endoscopy at 25.8% of the total. Reporting peaked in 2021 at $92,973 and has fallen 91.0% since, to $8,399 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$320,643in general payments, 2019–2025

Across 275 payments — averaging $1165.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

US Endoscopy$83K
CSA Medical, Inc$79K
Boston Scientific$48K
Covidien LP$42K
Medtronic$40K
Johnson & Johnson$8K
plus $21K from 16 others

$96,009in research payments, 2019–2025

Across 22 payments — averaging $4364.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$96K

What the payments were for

Consulting fees$209,12065%
Speaking & faculty fees$44,05014%
Travel & lodging$43,84214%
Food & beverage$20,0616%
Education$3,5001%
Gifts$700%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
US Endoscopy	31	$82,713
CSA Medical, Inc	4	$79,265
Boston Scientific	38	$47,573
Covidien LP	17	$42,091
Medtronic	91	$40,160
Johnson & Johnson	3	$7,575
Ambu Inc.	1	$4,988
Intuitive Surgical	18	$4,462
Steris Corporation	21	$4,047
Zimmer Biomet	20	$3,258
Atricure, Inc.	14	$2,444
Ambu A/s	1	$688
AstraZeneca	1	$525
On Target Laboratories, Inc	1	$252
Baxter Healthcare	6	$173
Biom'up France SAS	1	$126
Galvanize Therapeutics, Inc	1	$98
E.r. Squibb & Sons, L.L.C.	2	$71
Edwards Lifesciences	1	$65
Abiomed	1	$29
Abbott	1	$24
Pfizer	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TRUFREEZE$85,617
GENERAL PULMONARY$26,266
Signia$13,273
AGILE ESOPHAGEAL$2,500
DA VINCI SP$2,500
ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$2,042
WALLFLEX$1,500
Pectus Bar Bending Forceps, Standard$1,391
EXALT BX 2$1,000
DAVINCI XI$1,000
The Tether$965
GENERAL PAIN MANAGEMENT$701
MEDLINE$561
IMFINZI$525
GENERAL - THERAPIES$500
Da Vinci Surgical System$444
Cytalux$252
GENERAL - METAL STENTS - G.I.$127
HemoBlast Bellows$126
EXALT$101

How this compares

$320,643 in reported general payments places this provider in the 95th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.

See all thoracic surgery (cardiothoracic vascular surgery) providers in New York →

Medicare billing

Part B allowed, 2024

$86,755

Medicare patients

112

Services billed

218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in New York

Aubrey GallowayNew York$5.7M
Gilbert TangNew York$842K
Michael ZervosNew York$811K
Elias ZiasNew York$465K
Isaac GeorgeNew York$395K
Eugene GrossiNew York$350K
Brendon StilesNew York$314K
Daniela MolenaNew York$221K
Arnar GeirssonNew York$218K
Andrea WolfNew York$157K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →